Explore how breakthroughs in combinatorial chemistry, high-throughput screening, and genomics converged to redefine drug discovery and therapy in the 1990s.
Explore how automated dosing, sampling and LC/MSMS with ion traps and triple quads are revolutionizing pharmacokinetic research in drug discovery.
Discover how MIT researchers are using artificial intelligence to accelerate drug discovery and combat antibiotic resistance through innovative AI tools like DiffDock.
Explore how computational software and AI are accelerating drug discovery, from virtual screening to molecular dynamics, with real-world examples like COVID-19 antivirals.
Explore the evolution of chemogenomics from target-centric drug discovery to AI-driven network medicine and virtual patient models.
Discover how row-constrained supersaturated designs and Lasso regression are revolutionizing high-throughput drug screening to combat antibiotic resistance.